EMA in last push to thrash out detail of data disclosure policy
This article was originally published in SRA
Executive Summary
With June still firmly in its sights for the completion of its new policy on proactive publication of clinical trial data, the European Medicines Agency has announced that it will hold a final round of talks with key stakeholders in May to iron out any remaining issues1.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.